{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:15:18Z","timestamp":1787242518982,"version":"build-2736575974"},"reference-count":46,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Hearing impairment (HI) is a major problem in Ghana; however, the few attempts at shedding light on its causes appear to overlook the adverse effects of some medications\u2014a gap that this study sought to fill. Aminoglycoside therapy for tuberculosis (TB) treatment is one of these medications. Aim: The aim of this study was to establish the potential of aminoglycoside as a cause of hearing impairment among patients on anti-TB treatment. Method: This was a case\u2013control study, involving patients receiving treatment for TB with aminoglycoside at the chest clinic of the Tema General Hospital and a control group of age- and gender-matched healthy volunteers. A structured questionnaire was administered to obtain the demographic data and case history of the participants. The hearing sensitivity of the participants was assessed using conventional pure tone audiometry and transient evoked otoacoustic emission tests. Results: A hearing loss prevalence of 20% (12\/60) was found among patients receiving treatment for TB, with the intensity of impairment ranging from mild to severe. Hearing thresholds of patients receiving anti-TB medications were significantly elevated (p &lt; 0.05) in comparison to the thresholds of the control group, especially at the high frequencies. Conclusion: This study shows that aminoglycoside therapy for tuberculosis may contribute to hearing impairment among tuberculosis patients in Ghana. Audiological management of these patients should therefore be an essential part of their therapeutic treatment plan.<\/jats:p>","DOI":"10.3390\/diseases10010010","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T09:59:21Z","timestamp":1643709561000},"page":"10","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Aminoglycoside Therapy for Tuberculosis: Evidence for Ototoxicity among Tuberculosis Patients in Ghana"],"prefix":"10.3390","volume":"10","author":[{"given":"Enid","family":"Owusu","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra 233, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7236-7739","authenticated-orcid":false,"given":"Benjamin T.","family":"Amartey","sequence":"additional","affiliation":[{"name":"Department of Audiology, Speech and Language Therapy, School of Biomedical and Allied Health Sciences, University of Ghana, Accra 233, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Afutu","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Biomedical and Allied Health Sciences, University of Ghana, Accra 233, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Boafo","sequence":"additional","affiliation":[{"name":"Department of Audiology, Speech and Language Therapy, School of Biomedical and Allied Health Sciences, University of Ghana, Accra 233, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"ref_1","unstructured":"(2018, October 16). WHO 2018. Available online: https:\/\/www.who.int\/deafness\/world-hearing-day\/World-Hearing-Day-Infographic-EN.pdf?ua=1."},{"key":"ref_2","first-page":"110","article-title":"Characteristics of hearing-impairment among patients in Ghana","volume":"13","author":"Amedofu","year":"2006","journal-title":"Afr. J. Health Sci."},{"key":"ref_3","first-page":"11","article-title":"Prevalence of hearing loss in patients with acute otitis media","volume":"32","author":"Awuah","year":"2012","journal-title":"J. Sci. Technol."},{"key":"ref_4","unstructured":"Nyako, E.A. (2013). Prevalence of Hearing Impairment at the Korle-Bu Teaching Hospital. [Master\u2019s Thesis, University of Ghana-Legon]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1017\/S0022215119001658","article-title":"Paediatric hearing loss: A community-based survey in peri-urban Kumasi, Ghana","volume":"133","author":"Otupiri","year":"2019","journal-title":"J. Laryngol. Otol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/tmi.12533","article-title":"Otoacoustic emission testing in Ghanaian children with sickle-cell disease","volume":"20","author":"Kegele","year":"2015","journal-title":"Trop. Med. Int. Health"},{"key":"ref_7","first-page":"91","article-title":"Hearing-impairment among workers in a surface gold mining company in Ghana","volume":"9","author":"Amedofu","year":"2002","journal-title":"Afr. J. Health Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"892105","DOI":"10.1155\/2014\/892105","article-title":"Night-time decibel hell: Mapping noise exposure zones and individual annoyance ratings in an urban environment in Ghana","volume":"2014","author":"Zakpala","year":"2014","journal-title":"Scientifica"},{"key":"ref_9","unstructured":"WHO (2018, August 11). Tuberculosis. WHO; World Health Organization. Available online: http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/jphe.2016.12.08","article-title":"Tuberculosis\u2014an overview","volume":"1","author":"Agyeman","year":"2017","journal-title":"J. Public Health Emerg."},{"key":"ref_11","first-page":"1373","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis","volume":"9","author":"Maden","year":"2005","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"Yildiz","year":"2006","journal-title":"Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e7482","DOI":"10.1097\/MD.0000000000007482","article-title":"Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: A retrospective study","volume":"96","author":"Yang","year":"2017","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5002434","article-title":"Ototoxicity","volume":"72","author":"Rybak","year":"2007","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"B","DOI":"10.2471\/BLT.07.043802","article-title":"Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment","volume":"86","author":"Awofeso","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_16","unstructured":"BSA (2019, September 17). Pure-Tone Air-Conduction and Bone-Conduction Threshold Audiometry with and without Masking. Available online: https:\/\/www.bshaa.org\/bsa-procedure-for-pure-tone-air-conduction-and-bone-conduction-threshold-audiometry-with-and-without-masking\/."},{"key":"ref_17","unstructured":"Swanepoel, D.W., and Laurent, C. (2018, August 11). Open Access Guide to Audiology and Hearing Aids for Otolaryngologists- Classification of Hearing Loss. Available online: https:\/\/vula.uct.ac.za\/access\/content\/group\/27b5cb1b-1b65-4280-."},{"key":"ref_18","first-page":"257","article-title":"Infection control for audiologists","volume":"Volume 3","author":"Roeser","year":"2000","journal-title":"Audiology: Practice Management"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Duggal, P., and Sarkar, M. (2007). Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear., 7.","DOI":"10.1186\/1472-6815-7-5"},{"key":"ref_20","first-page":"31","article-title":"Ototoxicity among patients receiving Multidrug-Resistant tuberculosis treatment; Experience from a tertiary care hospital","volume":"23","author":"Javaid","year":"2018","journal-title":"Pak. J. Chest Med."},{"key":"ref_21","first-page":"622","article-title":"Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis","volume":"6","year":"2002","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jac\/dkr221","article-title":"Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: A study of injectable use and toxicity in practice","volume":"66","author":"Sturdy","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S1806-37132012000100012","article-title":"Audiometric evaluation of patients treated for pulmonary tuberculosis","volume":"38","author":"Vasconcelos","year":"2012","journal-title":"J. Bras. De Pneumol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1755-7682-5-3","article-title":"Cochleo-vestibular clinical findings among drug resistant Tuberculosis Patients on therapy-a pilot study","volume":"5","author":"Ramma","year":"2012","journal-title":"Int. Arch. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sagwa, E.L., Ruswa, N., Mavhunga, F., Rennie, T., Leufkens, H.G.M., and Mantel-Teeuwisse, A.K. (2015). Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort. BMC Pharmacol. Toxicol., 16.","DOI":"10.1186\/s40360-015-0036-7"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0795-3038.197748","article-title":"Pure tone audiometric findings in patients on second-line treatment for multidrug-resistant tuberculosis","volume":"10","author":"Ibekwe","year":"2016","journal-title":"Port Harcourt Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1590\/s1806-37562016000000165","article-title":"Hearing thresholds in patients with drug-resistant tuberculosis: Baseline audiogram configurations and associations","volume":"43","author":"Sogebi","year":"2017","journal-title":"J. Bras. De Pneumol."},{"key":"ref_29","unstructured":"Roland, P., and Rutka, J. (2004). Mechanisms for Aminoglycoside Ototoxicity: Basic Science Researcher. Ototoxicity, BC Decker, Inc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"937861","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection","volume":"2011","author":"Huth","year":"2011","journal-title":"Int. J. Otolaryngol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI112463","article-title":"Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs","volume":"77","author":"Huy","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(95)01198-6","article-title":"Endocytosis of aminoglycoside antibiotics in sensory hair cells","volume":"704","author":"Hashino","year":"1995","journal-title":"Brain Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/00206099309072930","article-title":"Gentamicin uptake by cochlear hair cells precedes hearing impairment during chronic treatment","volume":"32","author":"Hiel","year":"1993","journal-title":"Audiology"},{"key":"ref_34","first-page":"207","article-title":"Aminoglycoside toxicity and relation to dose regimen","volume":"13","author":"Barclay","year":"1994","journal-title":"Advers. Drug React. Toxicol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"Guthrie","year":"2008","journal-title":"Toxicology"},{"key":"ref_36","first-page":"879","article-title":"Intracellular mechanisms of aminoglycoside-induced cytotoxicity","volume":"3","author":"Karasawa","year":"2011","journal-title":"Integr. Biol. Quant. Biosci. Nano Macro"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.2174\/092986711797535254","article-title":"Ototoxicity: Mechanisms of cochlear impairment and its prevention","volume":"18","author":"Tabuchi","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7196\/SAMJ.4964","article-title":"Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients","volume":"102","author":"Harris","year":"2012","journal-title":"S. Afr. Med. J."},{"key":"ref_39","first-page":"72","article-title":"Hearing Loss among Multi-Drug Resistant Tuberculosis patients on Kanamycin in Ndola Teaching Hospital, Zambia: Study of ototoxicity and practice","volume":"1","author":"Mwansasu","year":"2017","journal-title":"Health Press Zamb. Bull"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.18203\/2320-6012.ijrms20150261","article-title":"Assessment of hearing loss in multi-drug resistant tuberculosis (MDR-TB) patients undergoing Aminoglycoside treatment","volume":"3","author":"Nizamuddin","year":"2015","journal-title":"Int. J. Res. Med. Sci."},{"key":"ref_41","first-page":"203","article-title":"Audiological evaluation of patients taking kanamycin for multidrug resistant tuberculosis","volume":"28","author":"Sharma","year":"2016","journal-title":"Iran. J. Otorhinolaryngol."},{"key":"ref_42","first-page":"2279","article-title":"Ototoxicity Associated with The Usage of Injectable Kanamycin in Multi-Drug Resistant Tuberculosis Patientsduring Intensive Phase of Category IV Treatment on DOTS-Plus Therapy","volume":"15","author":"Tiwari","year":"2016","journal-title":"IOSR J. Dent. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Modongo, C., Sobota, R.S., Kesenogile, B., Ncube, R., Sirugo, G., Williams, S.M., and Zetola, N.M. (2014). Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-542"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/oemed-2011-100106","article-title":"Hearing profile of gold miners with and without tuberculosis","volume":"69","author":"Brits","year":"2012","journal-title":"Occup. Env. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bbrc.2010.02.075","article-title":"Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides","volume":"393","author":"Human","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(01)00224-6","article-title":"Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals","volume":"155","author":"Sha","year":"2001","journal-title":"Hear. Res."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/10\/1\/10\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:12:19Z","timestamp":1760134339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/10\/1\/10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["diseases10010010"],"URL":"https:\/\/doi.org\/10.3390\/diseases10010010","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}